Allium Financial Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$323K Sell
5,941
-300
-5% -$14.6K 0.21% 58
2026
Q1
$268K Sell
6,241
-125
-2% -$5.37K 0.21% 64
2025
Q4
$279K Hold
6,366
0.22% 57
2025
Q3
$263K Sell
6,366
-500
-7% -$20.1K 0.22% 63
2025
Q2
$303K Hold
6,866
0.26% 59
2025
Q1
$253K Buy
+6,866
New +$245K 0.23% 63

Other funds holding EXEL

Allium Financial Advisors's EXEL Position: Q2 2026 in Review

Allium Financial Advisors reduced its Exelixis (EXEL) stake by 4.8% in Q2 2026, selling an estimated $14.6K and leaving 5,941 shares worth $323K. The position accounts for 0.21% of the portfolio, ranked #58.

Allium Financial Advisors first reported a position in EXEL in Q1 2025 and has held it in 6 quarters since. 759 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Allium Financial Advisors held 5,941 shares of Exelixis worth $323K as of Q2 2026.
  • Allium Financial Advisors sold 300 Exelixis shares in Q2 2026, an estimated $14.6K.
  • Exelixis made up 0.21% of Allium Financial Advisors's portfolio in Q2 2026, its #58 holding.
  • Allium Financial Advisors first reported a position in Exelixis in Q1 2025 and has held it in 6 quarters since.
  • 759 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Allium Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.